Calcimedica, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
Alafi Capital Company LLC and Christopher D. Alafi have reported beneficial ownership of 17.1% of CalciMedica, Inc. common stock following a recent private placement.
NASDAQ
Bering Partners II, L.P. and related entities have disclosed their beneficial ownership of CalciMedica, Inc. common stock, representing a 6.9% stake following a recent private placement.
NASDAQ
Valence Investments and key individuals report changes in beneficial ownership of CalciMedica, Inc. common stock, including participation in a recent public offering.